← Leaderboards
Thomas Radomski
University Of Pittsburgh At Pittsburgh
$2,556,012
Attributed
$4,169,950
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,169,950 · 3
VA$0 · 1
By mechanism
TL1$1,930,340 · 1
U24$1,297,536 · 1
K23$942,074 · 1
I01$0 · 1
Top collaborators
- Doris M Rubio2 shared
- Michael J Schneider1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Doris M Rubio$15,497,065
- Barbara A. Epstein$8,085,601
- Gwendolyn A Sowa$4,670,730
- Nam V Vo$9,841,127
- Brian M Miller$139,570
Others in their field
Other Emerging Leaders on “Design”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- John E West · University Of Texas At Austin$113,883,001
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
DesignMentorsResearch PersonnelSkillsEnsureTrainingK-Series Research Career ProgramsPublishingPhysiciansQualitative ResearchPharmaceutical PreparationsPharmacy FacilityPolypharmacyProviderCaringAdverse Drug EventFocus GroupsCostHospitalizationCaregiversHealth PersonnelGrantAgedHealth System
Grant awards (9)
A Virtual Center for Collaborative Research in Complementary and Integrative Health Institutions$1,297,536
U24 · FY2025 · AT
J. NRSA Training Core$930,444
TL1 · FY2025 · TR · contact PI
EVOLV-Rx VA: Evaluating Opportunities to Decrease Low-Value Prescribing in Community Living Centers$0
I01 · FY2025 · VA · contact PI
J. NRSA Training Core$999,896
TL1 · FY2024 · TR · contact PI
The Development, Validation, and Application of a Claims-based Metric of Low Value Prescribing in Older Adults$185,940
K23 · FY2023 · AG · contact PI
The Development, Validation, and Application of a Claims-based Metric of Low Value Prescribing in Older Adults$188,516
K23 · FY2022 · AG · contact PI
The Development, Validation, and Application of a Claims-based Metric of Low Value Prescribing in Older Adults$188,868
K23 · FY2021 · AG · contact PI
The Development, Validation, and Application of a Claims-based Metric of Low Value Prescribing in Older Adults$189,210
K23 · FY2020 · AG · contact PI
The Development, Validation, and Application of a Claims-based Metric of Low Value Prescribing in Older Adults$189,540
K23 · FY2019 · AG · contact PI